Evidence map›Paper›PMID 37714926›Full record

ArticleLeukemia2023

Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study).

Wei Jiang, Selmir Avdic, Koon H Lee, Janine Street, Gloria Castellano-González, Renee Simms, Leighton E Clancy, Richard Blennerhassett, Ellis Patrick, Adam S Chan and 8 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Adoptive T-cell therapy for virus-associated diseases.Clinical microbiology reviews · 2025
    Review
  2. Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  3. Review
  4. Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wei JiangSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.ORCID 0000-0002-1049-7239
Selmir AvdicSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Koon H LeeSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Janine StreetWestmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
Gloria Castellano-GonzálezWestmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
Renee SimmsSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Leighton E ClancyResearch and Education Network, Western Sydney Area Health Service, Westmead, NSW, Australia.
Richard BlennerhassettBlood Transplant and Cell Therapies Program, Department of Haematology, Westmead Hospital, Westmead, NSW, Australia.
Ellis PatrickWestmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
Adam S ChanSchool of Mathematics and Statistics, Faculty of Science, University of Sydney, Camperdown, NSW, Australia.ORCID 0000-0001-9949-0342
Helen M McGuireCharles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia.
Nadav MyersWestmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
Brian S GlossWestmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
Melissa GabrielBlood Transplant and Cell Therapies Unit, The Children's Hospital at Westmead, Westmead, NSW, Australia.
Caroline M BatemanSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Ken MicklethwaiteSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
David J GottliebSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Emily BlythSydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia. emily.blyth@sydney.edu.au.ORCID 0000-0002-7849-7139

Funding

Department of Health | National Health and Medical Research Council (NHMRC) PG1088118
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationMyeloproliferative DisordersNeoplasmsHumansStem Cell TransplantationT-Lymphocytes

Identifiers

PMID37714926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.